Security key
00461U105
Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)
CUSIP: 00461U105
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.00001 par value
- Shares outstanding
- 138,752,791
- Total 13F shares
- 83,739,024
- Share change
- -3,756,310
- Total reported value
- $252,051,598
- Price per share
- $3.01
- Number of holders
- 122
- Value change
- -$10,906,407
- Number of buys
- 55
- Number of sells
- 46
Report period
Q4 2025
Institutions
122
Top holders
10
ACRS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Aclaris Therapeutics, Inc. SEC filings
Aclaris Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00461U105
Recent filing periods:
Ownership snapshot
Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Bonita Biotech (HK) Ltd
13D/G signal
Bonita Biotech (HK) Ltd
Evidence rows
50
Latest as of
31 Dec 2025
13D/G
13F
Lead comparable stake: 9.4%
13D/G row: Bonita Biotech (HK) Ltd
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bonita Biotech (HK) Ltd |
13D/G
Biosion, Inc.
|
9.4%
|
$33,944,003
11,281,950 shares
|
$0 | 09 Dec 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
6.2%
|
$20,164,873
6,700,629 shares
|
+$3,698,306 | 31 Dec 2025 |
| Adage Capital Management, L.P. |
13D/G
|
4.9%
|
$10,028,474
5,278,144 shares
|
-$5,554,080 | 30 Sep 2025 |
| Rock Springs Capital Management LP |
13F
13D/G
Company
|
4.7%
from 13D/G
|
$8,757,687
4,609,309 shares
|
— | 30 Sep 2025 |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
Company
|
3.5%
|
$5,449,080
3,837,380 shares
|
-$2,422,176 | 30 Jun 2025 |
| BML Capital Management, LLC |
13F
Company
|
10%
|
$27,075,000
14,250,000 shares
|
— | 30 Sep 2025 |
| Vivo Capital, LLC |
13F
Company
|
6.4%
|
$16,888,887
8,888,888 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
4.7%
|
$12,379,370
6,515,458 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
122
Shares
83,739,024
Rows loaded
122
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
103
Q4 2025 holders
122
Holder diff
19
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend